Author

F. Campagne

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:mouse· 3 Assay:bulk RNA-seq· 2 Research Focus:host-pathogen & immune response· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:development & morphogenesis· 1 Research Focus:differential expression· 1

Frequent Co-Authors

H. Zhao· 3 shared L. Blanc· 3 shared P. Chandakkar· 3 shared P. Marambaud· 3 shared S. Ruiz· 3 shared C. Metz· 2 shared J. Papoin· 2 shared P. Chatterjee· 2 shared

Activity by Year

2016-2019 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 42 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCell Biology

H. Zhao

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Sirolimus plus nintedanib treats vascular pathology in HHT mouse models

S. Ruiz, H. Zhao, P. Chandakkar, J. Papoin, H. Choi, A. Nomura-Kitabayashi, R. Patel, M. Gillen, L. Diao, P. Chatterjee, M. He, Y. Al-Abed, P. Wang, C. Metz, S. P. Oh, , P. Marambaud

This study shows that combining sirolimus and nintedanib treats vascular abnormalities in HHT mouse models by targeting multiple pathways.

bioRxiv · Aug 18, 2019 · PreprintCell Biology

Tacrolimus Rescues Endothelial ALK1 Loss-Of-Function Signaling And Improves HHT Vascular Pathology

S. Ruiz, P. Chandakkar, H. Zhao, J. Papoin, P. K. Chatterjee, E. Christen, C. N. Metz, L. Blanc, F. Campagne, P. Marambaud

This study identifies tacrolimus as a drug that activates Smad1/5/8 signaling and reduces vascular pathology in HHT models.

bioRxiv · May 13, 2017Cell Biology

A mouse model of hereditary hemorrhagic telangiectasia generated by transmammary-delivered immunoblocking of BMP9 and BMP10

S. Ruiz, H. Zhao, P. Chandakkar, P. Chatterjee, L. Blanc, C. Metz, F. Campagne, P. Marambaud

This study uses transmammary delivery of anti-BMP9/10 antibodies to induce HHT-like vascular defects in mouse neonates, revealing consistent retinal pathology and increased angiopoietin-2 expression.

bioRxiv · Nov 2, 2016Cell Biology